Bringing innovative medical technology to market today is increasingly more complex and competitive as it’s ever been for entrepreneurs and startups. One of the major hurdles for any early-stage healthcare company is funding.

Faced with the financing challenge, healthcare companies need to get creative and cast their nets widely for new sources. Non-VC sources of financing are gaining popularity and providing medical technology entrepreneurs with more choices than previously available.

Emerging healthcare firms that have developed value-driven patent portfolios can maximize opportunities for investment and partnering deals. Besides building a strategic patent portfolio, early-stage healthcare/medical technology companies should consider the following tips to become attractive targets for investors.

0

  • Focus on innovation:  Early-stage companies can sometimes act as outsourced R&D laboratories for larger players. Investors desire access to next-generation technology that disrupts medtech markets, even if regulatory approval is years away.

  • Think long-term: Early-stage firms should plan for investment and partnering deals years in advance. Larger medical device companies are concerned about limiting risk and often monitor a product for years to get comfortable with the technology and management team before investing.

  • Start de-risking on day one:  A medtech startup should address its regulatory, intellectual property, and reimbursement strategies from the beginning in lockstep with its investment plan and exit strategy.

  • Show commercial potential: Strong initial sales or adoption in hospitals and clinics demonstrates the commercial potential of a new medical technology.

0

GRA’s team of experts has good relationships in the venture capital and private equity sectors. Thanks to our experience, it is easy for us to identify the right investors and address them in a targeted manner. We also advise you on the structuring of the investment and the associated due diligence processes.

0

0

0

We take a holistic and integrated view of what is happening in lifesciences today and help your company to manage the future.